Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1439-1444

  Jacewicz, Mary S ^a   Acheson, David W K ^a   Binion, David G ^b   West, Gail A ^c   Lincicome, Lisa L ^a   Fiocchi, Claudio ^c   Keusch, Gerald T ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; INTERLEUKIN 8; RECEPTOR; SHIGA TOXIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENE EXPRESSION; HEMORRHAGIC COLITIS; HUMAN; HUMAN CELL; INTESTINE; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0032978683     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1439-1444.1999     Document Type: Article

References (29)

1. Acheson, D. W. K., R. Moore, S. De Breucker, L. Lincicome, M. Jacewicz, E. Skutelsky, and G. T. Keusch. 1996. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect. Immun. 64:3294-3300.
2. Acheson, D., M. Jacewicz, L. Lincicome, D. Bielinski, D. Binion, G. West, C. Fiocchi, and G. Keusch. 1997. Shiga toxin action on human intestinal microvascular endothelial cells (HIMEC), abstr. B-160, p. 56. In Abstracts of the 97th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
3. Baggiolini, M., and I. Clark-Lewis. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 307:97-101.
4. Binion, D. G., D. E. Orosz, S. Kugasthan, K. A. Miller, S. Fu, K. T. Wilson, N. P. Ziats, S. E. Emancipator, J. W. Jacobberger, G. T. Keusch, and C. Fiocchi. 1997. Generation and characterization of immortalized human intestinal microvascular endothelial cell lines (HIMEC-CMVT). Gastroenterology 112:A936. (Abstract.)
5. Binion, D. G., G. A. West, K. Ina, N. P. Ziats, S. N. Emancipator, and C. Fiocchi. 1997. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112:1895-1907.
6. Donohue-Rolfe, A., D. W. K. Acheson, A. V. Kane, and G. T. Keusch. 1989. Purification of Shiga and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and the production of cross-reactive monoclonal antibodies. Infect. Immun. 57:3888-3893.
7. Fitzpatrick, M. M., V. Shah, R. S. Trompeter, M. J. Dillon, and T. M. Barratt. 1992. Interleukin-8 and polymorphoneutrophil leukocyte activation in hemolytic uremic syndrome of childhood. Kidney Int. 42:951-956.
8. Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 108:705-712.
9. Haraldsen, G., J. Rugtveit, D. Kvale, T. Scholz, W. A. Muller, T. Hovig, and P. Brandtzaeg. 1995. Isolation and long term culture of human intestinal microvascular endothelial cells. Gut 37:225-234.
10. Haraldsen, G., D. Kvale, B. Lien, I. N. Farstad, and P. Brandtzaeg. 1996. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal microvascular endothelial cells. J. Immunol. 156:2558-2565.
11. Hofmann, S. L. 1993. Southwestern internal medicine conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. Am. J. Med. Sci. 306:398-406.
12. Hutchison, J., D. Stanimirovic, A. Shapiro, and G. Armstrong. 1997. Verotoxin causes cytotoxicity in human cerebral endothelial cells, p. 323-328. In J. B. Kaper, and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, D.C.
13. Inokuchi, J., and N. S. Radin. 1987. Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-propanol, an inhibitor of murine glucocerebroside synthetase. J. Lipid Res. 28:565-571.
14. Jacewicz, M., H. A. Feldman, A. Donohue-Rolfe, and G. T. Keusch. 1989. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J. Infect. Dis. 159:881-889.
15. Jacewicz, M. S., M. Mobassaleh, S. K. Gross, K. A. Balasubramanian, P. F. Daniel, S. Raghavan, R. H. McCluer, and G. T. Keusch. 1994. Pathogenesis of Shigella diarrhea. XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J. Infect. Dis. 169:538-546.
16. Kaye, S. A., C. B. Louise, B. Boyd, C. A. Lingwood, and T. G. Obrig. 1993. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1β enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect. Immun. 61:3886-3891.
17. Keusch, G. T., and D. W. K. Acheson. 1997. Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin. Hematol. 34:106-116.
18. Keusch, G. T., D. W. K. Acheson, L. Aaldering, J. Erban, and M. Jacewicz. 1996. Comparison of the effect of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J. Infect. Dis. 173:1164-1170.
19. Louise, C. B., and T. G. Obrig. 1994. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression. Microvascular Res. 47: 377-387.
20. Louise, C. B., and T. G. Obrig. 1995. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J. Infect. Dis. 172:1397-1401.
21. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney, and T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268:15484-15488.
22. Page, C., M. Rose, M. Yacoub, and R. Pigott. 1992. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141:673-683.
23. Petzelbauer, P., J. R. Bender, J. Wilson, and J. S. Pober. 1993. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J. Immunol. 151:5062-5072.
24. Ramegowda, B., O. G. Fonseca, J. E. Samuel, and V. L. Tesh. 1997. Shiga toxin 1 (Stx1) interaction with human brain microvascular endothelial cells: cytokines as sensitizing agents, p. 71. In J. B. Kaper, and A. D. O'Brien (ed.), Program and abstracts of the 3rd International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections. American Society for Microbiology, Washington, D.C.
25. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
26. Richardson, S. E., M. A. Karmali, L. E. Becker, and C. R. Smith. 1990. The histopathology of the hemolytic uremic syndrome associated with verocyto-toxin-producing Escherichia coli infections. Hum. Pathol. 19:1102-1108.
27. Tesh, V. L., J. E. Samuel, L. P. Perera, J. B. Sharefkin, and A. D. O'Brien. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
28. Van de Kar, N. C., L. A. Monnens, and V. W. Van Hinsbergh. 1993. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid vero-toxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome. Behring Inst. Mitt. 92:202-209.
29. van Setten, P. A., V. W. van Hinsbergh, T. J. van der Velden, N. C. van der Kar, M. Vermeer, J. D. Mahan, K. J. Assmann, L. P. van den Heuvel, and L. Monnens. 1997. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int. 51:1245-1256.